Encoded Therapeutics is a clinical-stage biotechnology company developing one-time precision genetic medicines for severe monogenic and common neurological disorders. The company's vector engineering platform enables highly targeted and cell-type-selective control of gene expression in the brain and peripheral nervous system, allowing potent and precise modulation of disease-relevant genes to address underlying disease biology. Encoded's end'to'end innovation engine-spanning discovery, development, and in'house GMP manufacturing-creates a streamlined path to advance a diversified pipeline of one'time treatments across a broad range of neurological conditions. Encoded is driven by a mission to meaningfully improve the lives of patients and families affected by devastating neurological disorders.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/09/26	$275,000,000	Series F	ARCH Venture Partners Braidwell Farallon Capital Management GV Illumina Ventures Invus Janus Henderson Investors Matrix Capital Management Nolan Capital RTW Investments SoftBank Vision Fund 2 Venrock	undisclosed